NEK2 and cancer: T-1101 tosylate disrupts the interaction of NEK2 with one of its target proteins, Highly Expressed in Cancer 1 (Hec1), and therefore partially inhibits the NEK2 signaling pathway and induces apoptosis in cancer cells (16, 18).